This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Denovo Biopharma LLC. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Biography of Inventor Hong Sun
Introduction
Hong Sun is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of diagnostic methods for cancer treatment.
Latest Patents
Hong Sun holds a patent for "Methods and composition for the prediction of the activity of enzastaurin." This invention describes biomarkers that correlate with individual responses to enzastaurin, a drug used in treating various cancers, including DLBCL and GBM. The biomarkers can be utilized in companion diagnostic tests to predict drug responses, ensuring that treatments are tailored to benefit patients effectively.
Career Highlights
Hong Sun is currently associated with Denovo Biopharma LLC, where he continues to innovate in the field of personalized medicine. His work focuses on improving patient outcomes through the identification of biomarkers that guide treatment decisions.
Collaborations
Throughout his career, Hong has collaborated with various professionals in the field, including his coworker Wen Luo. These collaborations have enhanced the research and development of effective cancer therapies.
Conclusion
Hong Sun's contributions to biotechnology and cancer treatment exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also aims to improve the lives of patients facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile